Clinical Trial Update: Bioinformation Therapy for Liver Cancer [Phase 2, Phase 3]

View source ↗

Summary

An update on a Bioinformation Therapy trial for non-resectable liver cancer, noting completion of Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Liver, Cancer of, Non-Resectable | Phase 2, Phase 3 | Status: COMPLETED